Status:
RECRUITING
A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis
Lead Sponsor:
E-DA Hospital
Collaborating Sponsors:
National Yang Ming Chiao Tung University
The Industrial Technology Research Institute
Conditions:
Blepharoptosis
Device Usability
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
To develop a feedback-enabled magnetic device for management of blepharoptosis and evaluate its efficacy and safety, including the gain of palpebral fissure height, visual field obstruction, blurred v...
Detailed Description
The feedback-enabled magnetic device primarily comprises 2 matched pairs of one near-infrared light-emitting diode and one photodiode sensor, a magnetic actuator, an iron sheet (for affixing to the pa...
Eligibility Criteria
Inclusion
- Patients with ptosis; they are capable of understanding and complying with protocol requirements
- Aged 18 years old or older
Exclusion
- Upper eyelid scar, contracture, or fibrosis due to previous surgical intervention(s)
- Patients with psychiatric (or mental) disorders; they are unable to cooperate or follow the study procedure
- Children younger than 18 years of age
Key Trial Info
Start Date :
April 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03812016
Start Date
April 1 2023
End Date
December 31 2026
Last Update
May 14 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
E-Da Hospital
Kaohsiung City, Taiwan, 82445
2
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, Taiwan